Ivermectin Bolus. 80mg

Fenbendazole bolus

Fenbendazole bolus

composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s

composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s

composition: FMD antigen serotype -O, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s

Ivermectin oral tablet is used to treat parasitic infections of your intestinal tract, skin, and eyes.

Canine distemper (living), canine adeno virus (Living), canine parvo virus (living), canine adeno virus (inactivated) and leptospirosis vaccine, inactivated Freeze dried component Vial 1 coposition: Each single dose contains canine distemper virus (living ) B.P (Vet.) ≥ 10³ TCID50 [Propagated on vero cel...

Freeze dried component vial 1: Each single dose contains: canine distemper virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on vero cells]; canine adeno virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on MDCK cells]; canine parvo virus (living) B.P (Vet.) ≥ 103 TCID 50 (≥ 128HA units) [propagated on...

Megavac - P (Inact.) vaccine contains tissue culture adapted strain of canine parvovirus grown on A-72 cell cultures and inactivated with ß-propiolactone. Aluminium hydroxide gel is used as an adjuvant.

Canine parvo virus inactivated B.P (Vet.) Each dose (1mL) contains: inactivayted canine parvovirus antigen [propagated on A72 cells]adsorbed on to aluminium hydroxide gel, polymixin B.P as preservative 200 IU phosphate buffer diluent q.s to 1mL

Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.